Cornerstone Capital Management Holdings’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $1.03M | Buy |
22,180
+1,500
| +7% | +$69.7K | 0.01% | 898 |
|
|
2017
Q3 | $835K | Buy |
20,680
+2,200
| +12% | +$88.8K | 0.01% | 965 |
|
|
2017
Q2 | $626K | Sell |
18,480
-772
| -4% | -$26.2K | ﹤0.01% | 1002 |
|
|
2017
Q1 | $558K | Sell |
19,252
-59,675
| -76% | -$1.73M | ﹤0.01% | 1040 |
|
|
2016
Q4 | $2.59M | Sell |
78,927
-45,591
| -37% | -$1.5M | 0.02% | 667 |
|
|
2016
Q3 | $3.93M | Buy |
124,518
+71,052
| +133% | +$2.24M | 0.03% | 546 |
|
|
2016
Q2 | $1.5M | Sell |
53,466
-18,200
| -25% | -$512K | 0.01% | 803 |
|
|
2016
Q1 | $2.61M | Buy |
71,666
+13,739
| +24% | +$499K | 0.02% | 652 |
|
|
2015
Q4 | $2.32M | Buy |
57,927
+3,227
| +6% | +$129K | 0.02% | 694 |
|
|
2015
Q3 | $1.56M | Buy |
54,700
+37,000
| +209% | +$1.05M | 0.01% | 789 |
|
|
2015
Q2 | $583K | Sell |
17,700
-15,500
| -47% | -$511K | 0.01% | 963 |
|
|
2015
Q1 | $955K | Sell |
33,200
-25,000
| -43% | -$719K | 0.01% | 892 |
|
|
2014
Q4 | $1.58M | Sell |
58,200
-61,200
| -51% | -$1.67M | 0.02% | 779 |
|
|
2014
Q3 | $2.54M | Buy |
119,400
+47,200
| +65% | +$1.01M | 0.03% | 608 |
|
|
2014
Q2 | $1.62M | Sell |
72,200
-18,300
| -20% | -$411K | 0.02% | 764 |
|
|
2014
Q1 | $2.29M | Sell |
90,500
-70,577
| -44% | -$1.78M | 0.03% | 638 |
|
|
2013
Q4 | $3.7M | Sell |
161,077
-45,300
| -22% | -$1.04M | 0.04% | 468 |
|
|
2013
Q3 | $3.93M | Sell |
206,377
-47,500
| -19% | -$905K | 0.05% | 443 |
|
|
2013
Q2 | $3.66M | Buy |
+253,877
| New | +$3.66M | 0.05% | 461 |
|